Alembic Pharmaceuticals gains 3% on USFDA approval for hypertension drug News News / News 6 years ago 628 Views comments The company has received approval from United States Food Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Olmesartan... Read more
News Foreign investors may soon be allowed to trade in domestic commodities market News / News - 6 years ago
News IDBI Bank#39;s gross NPAs show Rs 6,816-cr divergence from RBI estimates for FY16 News / News - 6 years ago
Comments